This issue of Immunology and Allergy Clinics, guest edited by Dr. Andrew A. White, is devoted to Aspirin-Exacerbated Respiratory Disease. Articles in this issue include: An Overview of Non-Steroidal Anti-inflammatory Drug Reactions; The Clinical Presentation of Aspirin-Exacerbated Respiratory Disease; Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease; Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis; Pathogenesis of Aspirin Reactions in Aspirin-Exacerbated Respiratory Disease; Performing Aspirin Desensitization; Clinical Trials in Aspirin-Exacerbated Respiratory Disease Treatment; Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease; Mechanisms of Benefit with Aspirin Therapy; Lipid Mediators in Aspirin-Exacerbated Respiratory Disease; and Epigenetic and Genetic Components of Aspirin-Exacerbated Respiratory Disease.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. An Overview of Nonsteroidal Antiinflammatory Drug Reactions - p. 625 10. Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease - p. 643 11. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease - p. 657 12. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis - p. 669 13. Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease - p. 681 14. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease - p. 693 15. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease - p. 705 16. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease - p. 719 17. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease - p. 735 18. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease - p. 749 19. Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease - p. 765
This issue of Immunology and Allergy Clinics, guest edited by Dr. Andrew A. White, is devoted to Aspirin-Exacerbated Respiratory Disease. Articles in this issue include: An Overview of Non-Steroidal Anti-inflammatory Drug Reactions; The Clinical Presentation of Aspirin-Exacerbated Respiratory Disease; Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease; Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis; Pathogenesis of Aspirin Reactions in Aspirin-Exacerbated Respiratory Disease; Performing Aspirin Desensitization; Clinical Trials in Aspirin-Exacerbated Respiratory Disease Treatment; Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease; Mechanisms of Benefit with Aspirin Therapy; Lipid Mediators in Aspirin-Exacerbated Respiratory Disease; and Epigenetic and Genetic Components of Aspirin-Exacerbated Respiratory Disease.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. An Overview of Nonsteroidal Antiinflammatory Drug Reactions - p. 625 10. Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease - p. 643 11. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease - p. 657 12. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis - p. 669 13. Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease - p. 681 14. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease - p. 693 15. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease - p. 705 16. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease - p. 719 17. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease - p. 735 18. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease - p. 749 19. Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease - p. 765
